Drugs / TUBERVAC- Moscow strain
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06997367 Comparator | Mar → Sep 2025 overdue | tuberculosis | Bharat Biotech International Limited | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TUBERVAC- Moscow strain | “Comparator vaccine: BCG Vaccine (TUBERVAC- Moscow strain), manufactured by Serum Institute of India, is a freeze-dried powder containing an attenuated strain of Bacillus...” NCT06997367 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06997367 ↗ |
| Modality | Vaccine | “Comparator vaccine: BCG Vaccine (TUBERVAC- Moscow strain), manufactured by Serum Institute of India, is a freeze-dried powder containing an attenuated strain of Bacillus...” NCT06997367 ↗ |